Chat with us
Research Assistance
Online
  • Please enter your first name.

Italy Biological Skin Substitutes Market Size & Outlook

The biological skin substitutes market in Italy is expected to reach a projected revenue of US$ 16.8 million by 2033. A compound annual growth rate of 8.6% is expected of Italy biological skin substitutes market from 2026 to 2033.

  • HC Supplies
    • Wound Management
      • Biological Skin Substitutes Market Outlook
Revenue, 2025 (US$M)
$8.7
Estimate, 2026 (US$M)
$9.4
Forecast, 2033 (US$M)
$16.8
CAGR, 2026 - 2033
8.6%
Italy Biological Skin Substitutes Market, 2021-2033 (US$M)

This page contains premium content. Request sample data or start your free trial to explore Horizon.

  • ✔ Access to global market statistics
  • ✔ Access to company profiles
  • ✔ Free use-cases & research insights

No credit card required*

Global Market

Related Markets

Prism AI by Grand View ResearchFree to try

Ask a question about the biological skin substitutes market

Every figure cited from GVR research

Italy biological skin substitutes market highlights

  • The Italy biological skin substitutes market generated a revenue of USD 8.7 million in 2025 and is expected to reach USD 16.8 million by 2033.
  • The Italy market is expected to grow at a CAGR of 8.6% from 2026 to 2033.
  • In terms of segment, human donor tissue-derived products was the largest revenue generating type in 2025.
  • Human Donor Tissue-Derived Products is the most lucrative type segment registering the fastest growth during the forecast period.


Biological skin substitutes market data book summary

Market revenue in 2025USD 8.7 million
Market revenue in 2033USD 16.8 million
Growth rate8.6% (CAGR from 2026 to 2033)
Largest segmentHuman donor tissue-derived products
Fastest growing segmentHuman Donor Tissue-Derived Products
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationAcellular Animal-derived Products, Human Donor Tissue-Derived Products
Key market players worldwide3M Co, Organogenesis Holdings Inc Class A, Integra Lifesciences Holdings Corp, Smith & Nephew PLC, MiMedx Group Inc, Essity AB Class B, Stryker Corp, Vericel Corp, Mallinckrodt PLC Ordinary Shares - New, Tissue Regenix


Other key industry trends

  • In terms of revenue, Italy accounted for 2.3% of the global biological skin substitutes market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Europe, Germany biological skin substitutes market is projected to lead the regional market in terms of revenue in 2033.
  • Germany is the fastest growing regional market in Europe and is projected to reach USD 37.0 million by 2033.

According to Italy Country Profile 2021, heart diseases, stroke, lung cancer, COPD, and diabetes followed by COVID-19 were among the major causes of death in the country in 2020. The Italy Country Profile also reports that life expectancy in Italy was higher as compared to other European countries.

The high burden of chronic diseases and high life expectancy are expected to improve the demand for technologically advanced medical devices for diagnosis and treatment in the country. This is expected to create opportunities for medical device outsourcing services in the country.

A large number of key players in the medical device CDMOs are present in Italy, including Medpace, Charles River, Labcorp, Icon, IQVIA, Parexel, and PRA Health Science. The growing demand for reducing costs of clinical research, manufacturing, and development among medical device companies is expected to increase the number of partnerships with CDMOs in the coming years, thus boosting the Italy medical device outsourcing market.

No credit card required*

Customize the Report

20% free customization

Include
Countries, segments, points
Tailor
To your product definition
Extend
Deeper competitor detail
Or
A fully bespoke study

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Biological Skin Substitutes Market Companies

NameProfile# EmployeesHQWebsite
Stryker CorpView profile 52,0001941 Stryker Way, Portage, MI, United States, 49002www.stryker.com
3M CoView profile 85,0003M Center, St. Paul, MN, United States, 55144www.3m.com
Integra Lifesciences Holdings CorpView profile 3,9461100 Campus Road, Princeton, NJ, United States, 08540www.integralife.com
Smith & Nephew PLCView profile 18,452Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, United Kingdom, WD18 8YEwww.smith-nephew.com
Vericel CorpView profile 31464 Sidney Street, Cambridge, MA, United States, 02139www.vcel.com
Essity AB Class BView profile 45,900Klarabergsviadukten 63, PO Box 200, Stockholm, Sweden, SE-101 23www.essity.com
MiMedx Group IncView profile 8951775 West Oak Commons Court, NE, Marietta, GA, United States, 30062www.mimedx.com
Organogenesis Holdings Inc Class AView profile 86285 Dan Road, Canton, MA, United States, 02021www.organogenesis.com
Mallinckrodt PLC Ordinary Shares - NewView profile 2,700College Business and Technology Park, Cruiserath, Blanchardstown, Dublin, Ireland, 15www.mallinckrodt.com
Tissue RegenixView profile 51-100York, York, United Kingdom, Europewww.tissueregenix.com

Italy Biological Skin Substitutes Market Outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Biological Skin Substitutes Market Outlook will help companies and investors design strategic landscapes.


Human Donor Tissue-Derived Products was the largest segment with a revenue share of 72.41% in 2025.

Horizon Databook has segmented the Italy biological skin substitutes market based on acellular animal-derived products, human donor tissue-derived products covering the revenue growth of each sub-segment from 2021 to 2033.




According to Italy Country Profile 2021, heart diseases, stroke, lung cancer, COPD, and diabetes followed by COVID-19 were among the major causes of death in the country in 2020. The Italy Country Profile also reports that life expectancy in Italy was higher as compared to other European countries.

The high burden of chronic diseases and high life expectancy are expected to improve the demand for technologically advanced medical devices for diagnosis and treatment in the country. This is expected to create opportunities for medical device outsourcing services in the country.

A large number of key players in the medical device CDMOs are present in Italy, including Medpace, Charles River, Labcorp, Icon, IQVIA, Parexel, and PRA Health Science. The growing demand for reducing costs of clinical research, manufacturing, and development among medical device companies is expected to increase the number of partnerships with CDMOs in the coming years, thus boosting the Italy medical device outsourcing market.

  • Italy Biological Skin Substitutes Market Type Outlook (Revenue, USD Million , 2021-2033)
    • Human Donor Tissue-Derived Products
    • Acellular Animal-derived Products
  • Italy Biological Skin Substitutes Market Application Outlook (Revenue, USD Million , 2021-2033)
    • Acute wounds
    • Chronic wounds
  • Italy Biological Skin Substitutes Market End-Use Outlook (Revenue, USD Million , 2021-2033)
    • Hospitals
    • Outpatient Facilities
    • Research and Manufacturing

Reasons to subscribe to Biological Skin Substitutes Market Outlook databook

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Biological Skin Substitutes Market Outlook databook

  • Our clientele includes a mix of Biological Skin Substitutes Market Outlook companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Italy Biological Skin Substitutes Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Italy Biological Skin Substitutes Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Italy Biological Skin Substitutes Market, 2021-2033 (US$M)

No Access Stack Chart

Italy biological skin substitutes market statistics, by type, 2021-2033 (US$M)

No Access Pie Chart

Italy biological skin substitutes market statistics, by type, 2021-2033 (USD Million)

No Access

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more